<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01137058</url>
  </required_header>
  <id_info>
    <org_study_id>SNUBH_UH1</org_study_id>
    <nct_id>NCT01137058</nct_id>
  </id_info>
  <brief_title>Ubiquitous Healthcare for Elderly Patients With Type 2 Diabetes Mellitus</brief_title>
  <official_title>Clinical Efficacy of Ubiquitous Healthcare System for Elderly Patients With Type 2 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ubiquitous healthcare service for elderly patients with type 2 diabetes provides real-time
      glycemic monitoring and glucose control implemented by clinical decision support system
      (CDSS) using wire and wireless communication and information technology.

      To evaluate the clinical efficacy of this system, researchers plan to compare the improvement
      of glycemic control, self-management, and quality of life among three study groups: control,
      self glucose monitoring, and U-healthcare group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recently, the application of internet-based glucose control system showed better long term
      glucose control compared to the conventional treatment. This study has become the foundation
      of web-based methodology in the glucose control. In addition, the combined application of
      mobile device and web-based monitoring system for chronic diseases showed improvement in
      various metabolic parameters in obese patients with diabetes and hypertension.

      Thus, the application of U-healthcare based on advanced information technology would be
      helpful in the diabetes management. We plan to provide an individualized U-healthcare service
      using advanced information technology that enables more effective glucose control.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Target goal of HbA1c (&lt; 7.0%) without hypoglycemia</measure>
    <time_frame>24 weeks</time_frame>
    <description>Percent of patients who reach target goal of HbA1c (&lt; 7.0%) without hypoglycemia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>amount of exercise</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index (BMI) changes</measure>
    <time_frame>Body mass index</time_frame>
    <description>Comparison of body mass index changes among control, self monitoring of blood glucose (SMBG) and ubiquitous healthcare groups</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>U-healthcare</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>glucose meter and U-healthcare</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SMBG group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diabetic patients who do self monitoring of blood glucose only were categorized into self monitoring of blood glucose (SMBG) group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>conventional treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>U-healthcare service</intervention_name>
    <description>Public switched telephone network (PSTN)-connected glucometer with U-healthcare system.</description>
    <arm_group_label>U-healthcare</arm_group_label>
    <other_name>U-healthcare group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SMBG group</intervention_name>
    <description>Glucose control with self monitoring of blood glucose.</description>
    <arm_group_label>SMBG group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes

          -  age: 60 ~ 85 yrs

          -  HbA1c: 6.5%-11.0%

          -  duration of diabetes: less than 30 years

          -  BMI: 20-35

        Exclusion Criteria:

          -  systemic corticosteroid administered within previous 6 months

          -  history of myocardial ischemia

          -  Heart failure, NYHA Class II-IV

          -  Thyroid disease with abnormal TFT

          -  Anti-obesity drugs or slimming products within previous 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Soo Lim, MD, MPH, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2010</study_first_submitted>
  <study_first_submitted_qc>June 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2010</study_first_posted>
  <last_update_submitted>May 25, 2014</last_update_submitted>
  <last_update_submitted_qc>May 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Soo Lim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

